In invasive cancers, immunohistochemistry could detect the very weak signals of hScrib in the cytoplasm arbitrarily and no hScrib expression at the cell–cell boundaries, which reflects the disruption of cell–cell junctions and mislocalisation of junctional proteins in invasive cancers. Here, SCRIB is linked to cancer.